Roberson E D, Hesse J H, Rose K D, Slama H, Johnson J K, Yaffe K, Forman M S, Miller C A, Trojanowski J Q, Kramer J H, Miller B L
Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Neurology. 2005 Sep 13;65(5):719-25. doi: 10.1212/01.wnl.0000173837.82820.9f.
Frontotemporal lobar degeneration (FTLD) is a common cause of non-Alzheimer dementia, but its natural history and the factors related to mortality in affected patients are not well understood.
This retrospective, longitudinal study compared survival in FTLD (n = 177) with Alzheimer disease (AD; n = 395). Hazards analysis investigated the contribution of various demographic, neuropsychiatric, and neuropsychological variables and associated neurologic and neuropathologic findings.
The frontotemporal dementia (FTD) subtype of FTLD progressed faster than AD (median survival from retrospectively determined symptom onset, 8.7 +/- 1.2 vs 11.8 +/- 0.6 years, p < 0.0001; median survival from initial clinic presentation, 3.0 +/- 0.5 vs 5.7 +/- 0.1 years, p < 0.0001). Survival was similarly reduced in the related conditions corticobasal degeneration and progressive supranuclear palsy. Survival in the semantic dementia subtype of FTLD (11.9 +/- 0.2 years from onset and 5.3 +/- 0.4 years from presentation), however, was significantly longer than in FTD and did not differ from AD. Hazards analysis to determine factors affecting survival in FTLD showed no effect of age at onset, sex, education, family history, or neuropsychiatric profile. Among neuropsychological measures examined, impaired letter fluency had a significant association with reduced survival. Associated ALS significantly reduced survival in FTLD. The presence of tau-positive inclusions was associated with the slowest progression.
Frontotemporal lobar degeneration progresses more rapidly than Alzheimer disease, and the fastest-progressing cases are those with the frontotemporal dementia clinical subtype, coexisting motor neuron disease, or tau-negative neuropathology.
额颞叶变性(FTLD)是导致非阿尔茨海默病性痴呆的常见病因,但对其自然病程以及影响患者死亡率的相关因素了解尚少。
这项回顾性纵向研究比较了FTLD患者(n = 177)与阿尔茨海默病(AD;n = 395)患者的生存率。风险分析研究了各种人口统计学、神经精神和神经心理学变量以及相关的神经学和神经病理学发现的影响。
FTLD的额颞叶痴呆(FTD)亚型进展速度比AD更快(从回顾性确定的症状发作起的中位生存期,8.7±1.2年对11.8±0.6年,p < 0.0001;从首次临床就诊起的中位生存期,3.0±0.5年对5.7±0.1年,p < 0.0001)。在相关疾病皮质基底节变性和进行性核上性麻痹中,生存率同样降低。然而,FTLD的语义性痴呆亚型的生存期(从发病起11.9±0.2年,从就诊起5.3±0.4年)明显长于FTD,且与AD无差异。确定影响FTLD患者生存因素的风险分析显示,发病年龄、性别、教育程度、家族史或神经精神特征均无影响。在所检查的神经心理学指标中,字母流畅性受损与生存率降低显著相关。合并肌萎缩侧索硬化(ALS)显著降低了FTLD患者的生存率。tau阳性包涵体的存在与进展最慢相关。
额颞叶变性的进展速度比阿尔茨海默病更快,进展最快的病例是具有额颞叶痴呆临床亚型、并存运动神经元病或tau阴性神经病理学的患者。